![Joseph Romanelli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Romanelli
Direktör/Styrelseledamot på
KIMBERLY-CLARK CORPORATION
Förmögenhet: 4 M $ per 2026-09-30
Profil
Joseph Romanelli is currently President, Chief Executive Officer & Director at Tessera Therapeutics, Inc. since 2026.
Mr. Romanelli is Chief Executive Officer & Partner at Flagship Pioneering, LLC starting in 2026.
Mr. Romanelli serves as an Independent Director at Kimberly-Clark Corp.
beginning in 2024.
Former roles include Chief Executive Officer at CORXEL Pharmaceuticals (Shanghai) Co., Ltd. from 2021 to 2022.
Mr. Romanelli was Head-Investor Relations at Merck & Co., Inc. from 1996 to 2015.
Mr. Romanelli held the position of Head-Investor Relations at Schering-Plough Corp.
USA. Mr. Romanelli was President-Human Health International at Merck & Co., Inc. Education includes an undergraduate degree from the University of Delaware and an MBA from Gabelli School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-26 | 28 739 ( 0 % ) | 4 M $ | 2026-09-30 | |
| 2026-01-02 | 0 ( -.--% ) | - $ | 2026-09-30 |
Aktiva positioner av Joseph Romanelli
| Företag | Position | Start |
|---|---|---|
| KIMBERLY-CLARK CORPORATION | Direktör/Styrelseledamot | 2024-11-13 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Verkställande Direktör | 2026-07-23 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Verkställande Direktör | 2026-01-01 |
Tidigare kända positioner av Joseph Romanelli
| Företag | Position | Slut |
|---|---|---|
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
 Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Verkställande Direktör | 2022-07-01 |
| MERCK & CO., INC. | Investor Relations Kontakt | 2015-07-01 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Offentlig kommunikationskontakt | 2009-11-04 |
| MERCK & CO., INC. | Företagsledare/Principal | - |
Joseph Romanellis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
93
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Kimberly-Clark Corp.
 Kimberly-Clark Corp. Household/Personal CareConsumer Non-Durables Manufactures paper based products and provides cleaning solutions | Consumer Non-Durables |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gabelli School of Business
 Gabelli School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Health Technology |
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd.
Jixing Pharmaceutical Technology (Shanghai) Co. Ltd. BiotechnologyHealth Technology Develops and commercializes novel therapeutics for cardiometabolic diseases | Health Technology |
